Medicine for treating hepatic adipose infiltration and hepatic fibrosis

Abstract

The invention relates to a medicine for treating hepatic adipose infiltration and hepatic fibrosis. The medicine for treating the hepatic adipose infiltration and the hepatic fibrosis is prepared from the following bulk drugs: cordyceps sinensis, typha angustifolia, pericarpium citri reticulatae and semen pruni. The medicine provided by the invention has the effects that the contents of total cholesterol and TG (Triglyceride) in a liver can be quite obviously decreased; the rise, which is caused by a composite factor, of the vitality of ALT (alanine aminotransferase) and AST (aspartate aminotransferase) in a serum can be quite obviously decreased; further, the immunity can be improved; the hepatic fibroplasias can be obviously suppressed. The medicine for treating the hepatic adipose infiltration and the hepatic fibrosis is mainly used for invigorating spleen and kidney, eliminating blood stasis and removing dampness through diuresis; the effectiveness of treating the hepatic adipose infiltration is realized from the nature of a disease.

Description

Technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating fatty liver and liver fibrosis. Background technique [0002] With the improvement of living standards and the influence of various unhealthy lifestyles, the incidence of fatty liver is on the rise. People of different ages and different genders can develop fatty liver. Like hypertension and diabetes, fatty liver has become one of the common chronic diseases of contemporary people, becoming the second largest liver disease after viral hepatitis. It can progress to liver fibrosis, cirrhosis, and even liver cancer, and then develop into cirrhosis of the liver. The proportions of liver cancer and liver cancer are 5%-10% and 1%-2%, respectively. A large number of studies have confirmed the relationship between age, gender, obesity and metabolic abnormalities and the onset of fatty liver. Such a large number of patients have caused fatty liver to attract attentio...

AI Technical Summary

Problems solved by technology

(2) Obesity and overweight, too much fat accumulation in the body can lead to fatty liver, and too much fat in the liver will increase the burden on the liver, reduce the metabolic rate, and aggravate the degree of fatty liver

Western medicine often uses lipid-lowering drugs alone to deal with it, and the pathology of fatty liver is not only a problem of lipid-lowering, but also includes damage to liver function after fat infiltration in the liver, and simple use of Western medicine to lower lipids often produces side effects and damages liver function .Traditional Chinese medicine has the characteristics of multi-component, multi-target, and multi-pathway. However, most of the current Chinese medicines are mainly for lipid-lowering, and the problem of preventing liver fibrosis is not taken into account at the same time. It is difficult to exert the overall curative effect, and the therapeutic effect is limited.

Images